These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities. Blackburn MR; Aldrich M; Volmer JB; Chen W; Zhong H; Kelly S; Hershfield MS; Datta SK; Kellems RE J Biol Chem; 2000 Oct; 275(41):32114-21. PubMed ID: 10908569 [TBL] [Abstract][Full Text] [Related]
84. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. Blackburn MR; Volmer JB; Thrasher JL; Zhong H; Crosby JR; Lee JJ; Kellems RE J Exp Med; 2000 Jul; 192(2):159-70. PubMed ID: 10899903 [TBL] [Abstract][Full Text] [Related]
86. Evidence that IgE receptor stimulation increases adenosine release from rat basophilic leukaemia (RBL-2H3) cells. Lloyd HG; Ross L; Li KM; Ludowyke RI Pulm Pharmacol Ther; 1998 Feb; 11(1):41-6. PubMed ID: 9802962 [TBL] [Abstract][Full Text] [Related]
87. Modulation of adenosine effects in attenuation of ischemia and reperfusion injury in rat heart. Hirai K; Ashraf M J Mol Cell Cardiol; 1998 Sep; 30(9):1803-15. PubMed ID: 9769236 [TBL] [Abstract][Full Text] [Related]
89. Effects of adenosine deaminase inhibition on blood pressure in old spontaneously hypertensive rats. Tofovic SP; Kusaka H; Li P; Jackson EK Clin Exp Hypertens; 1998 Apr; 20(3):329-44. PubMed ID: 9605386 [TBL] [Abstract][Full Text] [Related]
90. Can adenosine deaminase inhibitors be cytoprotective agents? Barankiewicz J; Danks AM; Marangos PJ Adv Exp Med Biol; 1998; 431():395-9. PubMed ID: 9598099 [No Abstract] [Full Text] [Related]
91. Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury. Abd-Elfattah AS; Jessen ME; Lekven J; Wechsler AS Mol Cell Biochem; 1998 Mar; 180(1-2):179-91. PubMed ID: 9546645 [TBL] [Abstract][Full Text] [Related]
92. Dual cardiac microdialysis to assess drug-induced changes in interstitial purine metabolites: adenosine deaminase inhibition versus adenosine kinase inhibition. Manthei SA; Reiling CM; Van Wylen DG Cardiovasc Res; 1998 Jan; 37(1):171-8. PubMed ID: 9539871 [TBL] [Abstract][Full Text] [Related]
93. Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma? Polosa R; Holgate ST Thorax; 1997 Oct; 52(10):919-23. PubMed ID: 9404382 [No Abstract] [Full Text] [Related]
95. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Ledent C; Vaugeois JM; Schiffmann SN; Pedrazzini T; El Yacoubi M; Vanderhaeghen JJ; Costentin J; Heath JK; Vassart G; Parmentier M Nature; 1997 Aug; 388(6643):674-8. PubMed ID: 9262401 [TBL] [Abstract][Full Text] [Related]
96. Endogenous adenosine facilitates neurotransmission via A2A adenosine receptors in the rat superior colliculus in vivo. Ishikawa S; Saijoh K; Okada Y Brain Res; 1997 May; 757(2):268-75. PubMed ID: 9200756 [TBL] [Abstract][Full Text] [Related]
97. DNA antisense therapy for asthma in an animal model. Nyce JW; Metzger WJ Nature; 1997 Feb; 385(6618):721-5. PubMed ID: 9034188 [TBL] [Abstract][Full Text] [Related]
98. Release of adenosine from human sensitized lung fragments and its effect on antigen-induced mediator release. Konnaris K; Lloyd HG; Temple DM Pulm Pharmacol; 1996 Jun; 9(3):141-8. PubMed ID: 8948510 [TBL] [Abstract][Full Text] [Related]
99. Adenosine transport inhibition ameliorates postischemic hypoperfusion in pigs. Gidday JM; Kim YB; Shah AR; Gonzales ER; Park TS Brain Res; 1996 Sep; 734(1-2):261-8. PubMed ID: 8896833 [TBL] [Abstract][Full Text] [Related]
100. Nucleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine? Van Belle H Cardiovasc Res; 1993 Jan; 27(1):68-76. PubMed ID: 8458034 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]